Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leukemia 2Waldenstrom Macroglobulinemia 1Venous Thrombosis 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Ototoxicity 1Neoplastic Cells, Circulating 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Prolymphocytic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Inflammation 1Hodgkin Disease 1Hemangioma, Cavernous, Central Nervous System 1Heart Failure 1

Interventions

Tamoxifen 10Chemotherapy, Adjuvant 7Radiotherapy 5Early Intervention, Educational 5Psychiatric Rehabilitation 4Neoadjuvant Therapy 4Letrozole 4Counseling 4Behavior Therapy 4Anastrozole 4Methods 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Immunohistochemistry 3Gene Expression Profiling 3Biopsy 3Telemedicine 2Taxes 2Soybean Proteins 2Simvastatin 2Paclitaxel 2Medroxyprogesterone 2Fatty Acids, Omega-3 2Educational Status 2Docosahexaenoic Acids 2Curcumin 2Chromatography, High Pressure Liquid 2Brachytherapy 2telapristone acetate 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Carcinoma In Situ × Atorvastatin × Clear all
NCT00637481 2016-12-29

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
66 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡